lobbying_activities: 1879349

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1879349	ab3f09f7-8c56-4a9c-a7a9-26521009326d	Q3	CHAMBER HILL STRATEGIES	400645947	AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL)	2016	third_quarter	PHA	Implementation issues related to P.L. 113-54, the Drug Quality and Security Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2016-10-17T13:38:47.083000-04:00